|
|
|
16 Jun 2008 |
Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
|
|
16 Jun 2008 |
SuperGen's JAK2 Inhibitor, SGI-1252, Inhibits in Vivo Tumor Cell Proliferation
|
|
16 Jun 2008 |
Metabolex Completes Patient Enrollment in Phase 2 Trial of MBX-8025 fro Treatment of Dyslipidemia
|
|
16 Jun 2008 |
Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
|
|
16 Jun 2008 |
European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
|
|
15 Jun 2008 |
Higher initial dose of Glivec achieved better early responses than standard dose for patients with chronic myeloid leukemia
|
|
15 Jun 2008 |
Study of VIDAZA(R) in Higher-Risk Patients with Myelodysplastic Syndromes Reports Improved Overall Survival
|
|
15 Jun 2008 |
SuperGen's PIM Kinase Inhibitor, SGI-1776, Causes Tumor Regression in AML Xenograft Models
|
|
15 Jun 2008 |
Exelixis Presents Clinical Data Supporting the Safety and Initial Clinical Activity of XL228 in Chronic and Acute Leukemia
|
|
15 Jun 2008 |
Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
|
|
15 Jun 2008 |
Array BioPharma Presents Additional Positive Phase 1 Results in Two Programs at the 2008 Annual European Congress of Rheumatology
|
|
15 Jun 2008 |
NicOx announces blood pressure analysis from 301 phase 3 study for naproxcinod at EULAR
|
|
15 Jun 2008 |
Gilead Announces Interim 12-Month Phase III Study Results for Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
|
|
15 Jun 2008 |
Cytokinetics Provides Updates from Phase I Clinical Trials of CK-1827452
|
|
15 Jun 2008 |
Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Psudomonas Lung Infections
|
|
15 Jun 2008 |
MethylGene Initiates Second Phase I Clinical Trial With MGCD265, A Multi-Targeted (c-Met) Kinase Inhibitor in Patients With Solid Tumors
|
|
12 Jun 2008 |
Positive Phase I/II Data of IDX899 Confirm Potent Antiviral Activity and Favorable Safety Profile in Treatment-Naive HIV-Infected Patients
|
|
12 Jun 2008 |
GlaxoSmithKline receives marketing authorisation in the EU for Tyverb(R) (lapatinib), the first oral targeted therapy for ErbB2-positive breast cancer
|
|
12 Jun 2008 |
Rigel Initiates Two Phase 2b Clinical Trials of R788 in Rheumatoid Arthritis
|
|
12 Jun 2008 |
OPKO Acquires Rights to Novel Phase II Agent to Treat Viral Conjunctivitis
|
|
12 Jun 2008 |
Calando Pharmaceuticals Collaborates with City of Hope to Initiate Investigator Sponsored Clinical Trial Using IT-101 in Lymphoma Patients
|
|
12 Jun 2008 |
Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
|
|
12 Jun 2008 |
ChemoCentryx Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohn's Disease
|
|
12 Jun 2008 |
Incyte’s JAK Inhibitor Demonstrates Marked Clinical Benefits in Phase IIa Rheumatoid Arthritis Study
|
|
11 Jun 2008 |
EPIX Pharmaceuticals Initiates Second Trial in Phase 2b Program for Alzheimer's Disease
|
|
11 Jun 2008 |
Bristol-Myers Squibb and Pfizer Initiate New Study in the Apixaban Phase 3 Clinical Trial Program
|
|
11 Jun 2008 |
Ardea Biosciences Presents Inflammation Program Data for Arthritis and Gout at 2008 Annual European Congress of Rheumatology
|
|
11 Jun 2008 |
Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer
|
|
11 Jun 2008 |
Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis
|
|
10 Jun 2008 |
AstraZeneca Submits Seroquel XR(TM) in Europe for the Treatment of Major Depressive Disorder
|
|
10 Jun 2008 |
Acomplia (rimonabant) significantly improved glucose control in type 2 diabetes patients treated with insulin
|
|
10 Jun 2008 |
AtheroGenics Reports Clinical Data on Novel Anti-Inflammatory Anti-Oxidant Agent, AGI-1067, at American Diabetes Association Annual Meeting
|
|
10 Jun 2008 |
Ambien CR(R) Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder
|
|
10 Jun 2008 |
Results from one year study suggest Seretide/Advair provides important benefits for African American patients with asthma
|
|
10 Jun 2008 |
Qnexa Reduces Hemoglobin A1c by 1.2 Percent in 28 Weeks
|
|
10 Jun 2008 |
Pain Therapeutics and King Pharmaceuticals Announce Submission of New Drug Application for Remoxy
|
|
10 Jun 2008 |
Metabasis Presents Preclinical Results for MB07803, Its Product Candidate for Type 2 Diabetes, and Its Glucagon Antagonist Program at the American Diabetes Association Meeting
|
|
10 Jun 2008 |
CryoLife's BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery
|
|
10 Jun 2008 |
OSI Pharmaceuticals Presents Diabetes/Obesity Preclinical Compounds, PSN821 and PSN602, at Annual Meeting of the American Diabetes Association
|
|
10 Jun 2008 |
Synosia Begins Proof-of-Mechanism Trial For Nitisinone
|
|
10 Jun 2008 |
Incyte's Selective Oral Inhibitor of 11beta-HSD1 Demonstrates Improvements in Insulin Sensitivity and Lowers Cholesterol Levels in Type 2 Diabetics
|
|
10 Jun 2008 |
Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
|
|
10 Jun 2008 |
Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
|
|
10 Jun 2008 |
Allergan Announces Agreement to Acquire Aczone(R) Gel 5%
|
|
10 Jun 2008 |
Achillion Announces Additional Positive Top-Line Phase 2 Data for Elvucitabine
|
|
10 Jun 2008 |
Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimer's Disease
|
|
10 Jun 2008 |
Elixir Pharmaceuticals Announces New Data at the 2008 American Diabetes Association Annual Meeting
|
|
10 Jun 2008 |
Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
|
|
10 Jun 2008 |
Hollis-Eden Pharmaceuticals Reports Additional Positive Data from Phase I/II Clinical Trial with TRIOLEX(TM) Supporting Anti-Inflammatory Approach to Treating Type 2 Diabetes
|
|
10 Jun 2008 |
POZEN Demonstrates Bioequivalence to Enteric Coated Aspirin for PA32540
|
| |
|
Results 351 - 400 of 5255 |
